Tampa, FL, United States of America

Nicholas J Virca

This inventor holds 5 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hedgepath Pharmaceuticals, Inc.. Active years: 2015-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicholas J Virca. Retrieved from https://idiyas.com/inventor/nicholas-j-virca

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 100.0


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Nicholas J. Virca: A Pioneer in Cancer Treatment

Introduction

Nicholas J. Virca, based in Tampa, FL, is a notable inventor specializing in innovative cancer treatment methodologies. With a robust portfolio of five patents to his name, he has significantly contributed to the medical field, particularly in oncology by exploring the Hedgehog signaling pathway and its potential in treating various cancers.

Latest Patents

Among his most recent innovations are two significant patents that focus on the treatment of prostate cancer and lung cancer using Hedgehog pathway inhibitors. These patents detail methods for treating proliferation disorders, including prostate cancer, basal cell carcinoma, and other malignancies, by utilizing inhibitors of the Hedgehog pathway (HhP). Furthermore, they outline methods for effectively monitoring patients undergoing these treatments through biomarkers and other predictive criteria concerning treatment efficacy.

Career Highlights

Nicholas J. Virca is currently affiliated with Hedgepath Pharmaceuticals, Inc., where he actively engages in the development of groundbreaking treatments. His career is marked by a commitment to advancing healthcare through innovative drug development and an emphasis on scientific research and collaboration.

Collaborations

A significant collaboration in his career is with Francis E. O'Donnell, Jr., who shares a common goal of innovating cancer treatment approaches. Their teamwork exemplifies the synergy between talented individuals, driving innovation forward in the medical community.

Conclusion

Nicholas J. Virca's contributions to cancer treatment through his patented inventions exemplify the critical role of innovation in healthcare. With continued advancements in understanding complex biological pathways, his work remains pivotal in improving the outcomes for patients dealing with cancer. His dedication to research and collaboration marks him as an influential figure in the field of oncology. As he continues to develop novel treatments, the potential impact of his inventions is bound to resonate within the medical community and improve countless lives.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…